Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Y-mAbs Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16
Revenues0.00.013.9
            Revenue growth -100.0% 
Cost of goods sold0.00.017.0
Gross profit0.00.0-3.2
            Gross margin  -23.0%
Research and development34.314.3 
General and administrative9.04.93.2
EBIT-43.2-19.2-17.0
            EBIT margin  -123.0%
Pre-tax income-43.3-19.2-17.1
Income taxes0.00.00.0
            Tax rate0.0%0.0%0.0%
Net income-43.3-19.20.0
            Net margin  -0.1%
 
Diluted EPS($1.50)($0.99)($1.21)
Shares outstanding (diluted)28.819.40.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy